AKCEA THERAPEUTICS INC's ticker is AKCA and the CUSIP is 00972L107. A total of 68 filers reported holding AKCEA THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 0.93 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $1,281,000 | +33.7% | 70,588 | +0.9% | 0.00% | – |
| Q2 2020 | $958,000 | +14.6% | 69,969 | +19.7% | 0.00% | – |
| Q1 2020 | $836,000 | -14.7% | 58,445 | +1.0% | 0.00% | – |
| Q4 2019 | $980,000 | +14.2% | 57,838 | +3.8% | 0.00% | – |
| Q3 2019 | $858,000 | -36.7% | 55,747 | -3.6% | 0.00% | – |
| Q2 2019 | $1,355,000 | -22.1% | 57,803 | -5.9% | 0.00% | – |
| Q1 2019 | $1,740,000 | -5.5% | 61,418 | +0.5% | 0.00% | -100.0% |
| Q4 2018 | $1,842,000 | -1.6% | 61,093 | +14.3% | 0.00% | – |
| Q3 2018 | $1,872,000 | +39.6% | 53,458 | -5.5% | 0.00% | – |
| Q2 2018 | $1,341,000 | -19.5% | 56,558 | -13.0% | 0.00% | – |
| Q1 2018 | $1,665,000 | +49.7% | 64,984 | +1.5% | 0.00% | – |
| Q4 2017 | $1,112,000 | -21.3% | 64,036 | +25.4% | 0.00% | – |
| Q3 2017 | $1,413,000 | – | 51,068 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|